The aggressiveness level of ovarian tumor is of great importance for clinical treatment and prognosis. The purpose of this study is to explore the value of R2 * in evaluating the aggressiveness of ovarian tumors. The preliminary results showed that the R2 * value of malignant tumors was significantly higher than benign and borderline tumors. R2* is potentially a promising and valuable non-invasive method in evaluating the aggressiveness of ovarian tumors.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords